Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F, Maekawa S, Itakura Y, Kanayama A, Matsui A, Takano S, Yamaguchi T, Itakura J, Kitamura T, Inoue T, Sakamoto M, Yamauchi K, Okada S, Yamashita A, Sakamoto N, Itoh M, Enomoto N. Amemiya F, et al. Among authors: yamaguchi t. J Infect Dis. 2008 Feb 1;197(3):361-70. doi: 10.1086/525287. J Infect Dis. 2008. PMID: 18248300
DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer.
Matsui A, Yamaguchi T, Maekawa S, Miyazaki C, Takano S, Uetake T, Inoue T, Otaka M, Otsuka H, Sato T, Yamashita A, Takahashi Y, Enomoto N. Matsui A, et al. Among authors: yamaguchi t. Cancer Sci. 2009 Oct;100(10):1923-30. doi: 10.1111/j.1349-7006.2009.01272.x. Epub 2009 Jul 2. Cancer Sci. 2009. PMID: 19659606 Free article.
Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.
Maekawa S, Sakamoto M, Miura M, Kadokura M, Sueki R, Komase K, Shindo H, Komatsu N, Shindo K, Kanayama A, Ohmori T, Amemiya F, Takano S, Yamaguchi T, Nakayama Y, Kitamura T, Inoue T, Okada S, Enomoto N. Maekawa S, et al. Among authors: yamaguchi t. Hepatology. 2012 Nov;56(5):1611-21. doi: 10.1002/hep.25826. Hepatology. 2012. PMID: 22577043
Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.
Sato M, Maekawa S, Komatsu N, Tatsumi A, Miura M, Muraoka M, Suzuki Y, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Uetake T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Sato M, et al. Among authors: yamaguchi t. J Virol. 2015 Jun;89(11):6105-16. doi: 10.1128/JVI.03127-14. Epub 2015 Mar 25. J Virol. 2015. PMID: 25810555 Free PMC article.
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.
Shindo K, Maekawa S, Komatsu N, Tatsumi A, Miura M, Sato M, Suzuki Y, Matsuda S, Muraoka M, Amemiya F, Fukasawa M, Yamaguchi T, Nakayama Y, Uetake T, Inoue T, Sakamoto M, Sato T, Enomoto N. Shindo K, et al. Among authors: yamaguchi t. Mediators Inflamm. 2015;2015:687484. doi: 10.1155/2015/687484. Epub 2015 Sep 30. Mediators Inflamm. 2015. PMID: 26494948 Free PMC article.
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
Maekawa S, Sato M, Kuratomi N, Inoue T, Suzuki Y, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Sato T, Sakamoto M, Murakawa M, Nakagawa M, Asahina Y, Enomoto N. Maekawa S, et al. Among authors: yamaguchi t. J Gastroenterol. 2018 Jun;53(6):780-786. doi: 10.1007/s00535-017-1405-3. Epub 2017 Nov 1. J Gastroenterol. 2018. PMID: 29094205
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.
Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Suzuki Y, et al. Among authors: yamaguchi t. Hepatol Res. 2019 Jan;49(1):51-63. doi: 10.1111/hepr.13277. Epub 2018 Dec 27. Hepatol Res. 2019. PMID: 30350374
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.
Muraoka M, Maekawa S, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamauchi K, Yamaguchi T, Nakayama Y, Inoue T, Enomoto N. Muraoka M, et al. Among authors: yamaguchi t. Hepatol Commun. 2021 Nov;5(11):1927-1938. doi: 10.1002/hep4.1762. Epub 2021 Jul 28. Hepatol Commun. 2021. PMID: 34558819 Free PMC article.
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing.
Yamauchi K, Sato M, Osawa L, Matsuda S, Komiyama Y, Nakakuki N, Takada H, Katoh R, Muraoka M, Suzuki Y, Tatsumi A, Miura M, Takano S, Amemiya F, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Maekawa S, Enomoto N. Yamauchi K, et al. Among authors: yamaguchi t. Hepatol Commun. 2022 Jul;6(7):1634-1651. doi: 10.1002/hep4.1929. Epub 2022 Mar 31. Hepatol Commun. 2022. PMID: 35357088 Free PMC article.
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Matsuda S, Maekawa S, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Sato T, Yamashita A, Moriishi K, Enomoto N. Matsuda S, et al. Among authors: yamaguchi t. Hepatol Res. 2021 Jan;51(1):39-50. doi: 10.1111/hepr.13574. Epub 2021 Jan 11. Hepatol Res. 2021. PMID: 32961003
9,108 results